Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.

The Journal of clinical investigation | 2015

Leukemia stem cells (LSCs) are found in most aggressive myeloid diseases and contribute to therapeutic resistance. Leukemia cells exhibit a dysregulated developmental program as the result of genetic and epigenetic alterations. Overexpression of the RNA-binding protein Musashi2 (MSI2) has been previously shown to predict poor survival in leukemia. Here, we demonstrated that conditional deletion of Msi2 in the hematopoietic compartment results in delayed leukemogenesis, reduced disease burden, and a loss of LSC function in a murine leukemia model. Gene expression profiling of these Msi2-deficient animals revealed a loss of the hematopoietic/leukemic stem cell self-renewal program and an increase in the differentiation program. In acute myeloid leukemia patients, the presence of a gene signature that was similar to that observed in Msi2-deficent murine LSCs correlated with improved survival. We determined that MSI2 directly maintains the mixed-lineage leukemia (MLL) self-renewal program by interacting with and retaining efficient translation of Hoxa9, Myc, and Ikzf2 mRNAs. Moreover, depletion of MLL target Ikzf2 in LSCs reduced colony formation, decreased proliferation, and increased apoptosis. Our data provide evidence that MSI2 controls efficient translation of the oncogenic LSC self-renewal program and suggest MSI2 as a potential therapeutic target for myeloid leukemia.

Pubmed ID: 25664853 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: U24-CA114737
  • Agency: NCI NIH HHS, United States
    Id: U10-CA180827
  • Agency: NCI NIH HHS, United States
    Id: U10 CA180801
  • Agency: NCI NIH HHS, United States
    Id: R01 CA16865
  • Agency: NIDDK NIH HHS, United States
    Id: R01-DK101989-01A1
  • Agency: NIDDK NIH HHS, United States
    Id: K01DK084261-01
  • Agency: NCI NIH HHS, United States
    Id: CA180801
  • Agency: NCI NIH HHS, United States
    Id: R01 CA193842
  • Agency: NCI NIH HHS, United States
    Id: CA180794
  • Agency: NCI NIH HHS, United States
    Id: U10 CA180820
  • Agency: NCI NIH HHS, United States
    Id: U24 CA114737
  • Agency: NCI NIH HHS, United States
    Id: CA180791
  • Agency: NCI NIH HHS, United States
    Id: U10 CA180827
  • Agency: NCI NIH HHS, United States
    Id: U10 CA021115
  • Agency: NCI NIH HHS, United States
    Id: UG1 CA189859
  • Agency: NCI NIH HHS, United States
    Id: CA180820
  • Agency: NCI NIH HHS, United States
    Id: U24 CA196172
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK101989
  • Agency: NIDDK NIH HHS, United States
    Id: K01 DK084261
  • Agency: NCI NIH HHS, United States
    Id: P30 CA008748
  • Agency: NCI NIH HHS, United States
    Id: U10 CA180791
  • Agency: NCI NIH HHS, United States
    Id: CA189859
  • Agency: NCI NIH HHS, United States
    Id: U10 CA180794

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Gene Expression Omnibus (GEO) (tool)

RRID:SCR_005012

Functional genomics data repository supporting MIAME-compliant data submissions. Includes microarray-based experiments measuring the abundance of mRNA, genomic DNA, and protein molecules, as well as non-array-based technologies such as serial analysis of gene expression (SAGE) and mass spectrometry proteomic technology. Array- and sequence-based data are accepted. Collection of curated gene expression DataSets, as well as original Series and Platform records. The database can be searched using keywords, organism, DataSet type and authors. DataSet records contain additional resources including cluster tools and differential expression queries.

View all literature mentions